Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

The NCCN Older Adult Oncology Panel Remembers Arti Hurria.

Dotan E, Walter LC.

J Natl Compr Canc Netw. 2019 Feb 1;17(2):e1-e2. doi: 10.6004/jnccn.2019.0004. No abstract available.

3.

Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients.

White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD.

J Geriatr Oncol. 2018 Dec 17. pii: S1879-4068(18)30145-0. doi: 10.1016/j.jgo.2018.11.001. [Epub ahead of print] Review.

PMID:
30573201
4.

Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance).

Phipps AI, Shi Q, Zemla TJ, Dotan E, Gill S, Goldberg RM, Hardikar S, Jahagirdar B, Limburg PJ, Newcomb PA, Shields A, Sinicrope FA, Sargent DJ, Alberts SR.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):696-703. doi: 10.1158/1055-9965.EPI-17-0769. Epub 2018 Mar 21.

PMID:
29563133
5.

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.

Hyman DM, Rizvi N, Natale R, Armstrong DK, Birrer M, Recht L, Dotan E, Makker V, Kaley T, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar M.

Clin Cancer Res. 2018 Jun 15;24(12):2749-2757. doi: 10.1158/1078-0432.CCR-17-1775. Epub 2018 Mar 20.

PMID:
29559563
6.

Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis.

Koch C, Schwing AM, Herrmann E, Borner M, Diaz-Rubio E, Dotan E, Feliu J, Okita N, Souglakos J, Arkenau HT, Porschen R, Koopman M, Punt CJA, de Gramont A, Tournigand C, Zeuzem S, Trojan J.

Oncotarget. 2017 Dec 20;9(12):10272-10283. doi: 10.18632/oncotarget.23475. eCollection 2018 Feb 13.

7.

Adjusting Our Current Practice to Better Care for the Older Patient With Cancer.

Dotan E.

J Oncol Pract. 2017 Feb;13(2):103-104. doi: 10.1200/JOP.2016.019687. No abstract available.

PMID:
28972828
8.

Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation.

Dotan E.

Surg Oncol Clin N Am. 2017 Oct;26(4):719-728. doi: 10.1016/j.soc.2017.05.010. Epub 2017 Aug 4. Review.

PMID:
28923227
9.

Nutrition and Aging: a Practicing Oncologist's Perspective.

Jain R, Dotan E.

Curr Oncol Rep. 2017 Sep 7;19(11):71. doi: 10.1007/s11912-017-0630-5. Review.

PMID:
28884400
10.

Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Maggiore RJ, Dale W, Hurria A, Klepin HD, Chapman A, Dotan E, Mohile SG, Naeim A, Gajra A, Buss MK.

J Oncol Pract. 2017 Nov;13(11):e900-e908. doi: 10.1200/JOP.2017.022111. Epub 2017 Aug 24.

PMID:
28837375
11.

Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.

Dotan E, Cohen SJ, Starodub AN, Lieu CH, Messersmith WA, Simpson PS, Guarino MJ, Marshall JL, Goldberg RM, Hecht JR, Wegener WA, Sharkey RM, Govindan SV, Goldenberg DM, Berlin JD.

J Clin Oncol. 2017 Oct 10;35(29):3338-3346. doi: 10.1200/JCO.2017.73.9011. Epub 2017 Aug 17.

PMID:
28817371
12.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
13.

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A.

J Natl Compr Canc Netw. 2016 Nov;14(11):1357-1370.

PMID:
27799507
14.

Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.

Vijayvergia N, Li T, Wong YN, Hall MJ, Cohen SJ, Dotan E.

Cancer. 2016 Oct 15;122(20):3191-3198. doi: 10.1002/cncr.30077. Epub 2016 Jul 5.

15.

Gaps in nutritional research among older adults with cancer.

Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W.

J Geriatr Oncol. 2016 Jul;7(4):281-92. doi: 10.1016/j.jgo.2016.04.006. Epub 2016 Jul 5. Review.

16.

Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI.

Flannery M, Mohile SG, Dale W, Arora NK, Azar L, Breslau ES, Cohen HJ, Dotan E, Eldadah BA, Leach CR, Mitchell SA, Rowland JH, Hurria A.

J Geriatr Oncol. 2016 Jul;7(4):225-33. doi: 10.1016/j.jgo.2016.02.001. Epub 2016 Jul 5. Review.

17.

Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma.

Dotan E, Alpaugh RK, Ruth K, Negin BP, Denlinger CS, Hall MJ, Astsaturov I, McAleer C, Fittipaldi P, Thrash-Bingham C, Meropol NJ, Cohen SJ.

Pancreas. 2016 Sep;45(8):1131-5. doi: 10.1097/MPA.0000000000000619.

18.

Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.

Vijayvergia N, Dotan E, Devarajan K, Hatahet K, Rahman F, Ricco J, Lewis B, Gupta S, Cohen SJ.

J Geriatr Oncol. 2015 Nov;6(6):454-61. doi: 10.1016/j.jgo.2015.08.001. Epub 2015 Aug 18.

19.

Cancer-Related Fatigue, Version 2.2015.

Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39.

20.

Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.

Gajra A, Klepin HD, Feng T, Tew WP, Mohile SG, Owusu C, Gross CP, Lichtman SM, Wildes TM, Chapman AE, Dotan E, Katheria V, Zavala L, Akiba C, Hurria A; Cancer and Aging Research Group (CARG).

J Geriatr Oncol. 2015 Mar;6(2):133-40. doi: 10.1016/j.jgo.2014.12.002. Epub 2015 Feb 7.

21.

Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.

Dotan E, Devarajan K, D'Silva AJ, Beck A, Kloth DD, Cohen SJ, Denlinger C.

Clin Colorectal Cancer. 2014 Sep;13(3):192-8. doi: 10.1016/j.clcc.2014.05.003. Epub 2014 Jun 26.

22.

Refining the chemotherapy approach for older patients with colon cancer.

McCleary NJ, Dotan E, Browner I.

J Clin Oncol. 2014 Aug 20;32(24):2570-80. Review.

PMID:
25071118
23.

Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancer.

Dotan E, Li T, Hall MJ, Meropol NJ, Beck JR, Wong YN.

J Oncol Pract. 2014 Sep;10(5):308-14. doi: 10.1200/JOP.2014.001439. Epub 2014 Jul 22.

24.

Occult primary, version 3.2014.

Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):969-74.

PMID:
24994917
25.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR.

J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12.

26.

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB 3rd, Bergman MA, Sundar H.

J Natl Compr Canc Netw. 2014 Jan;12(1):82-126.

PMID:
24453295
27.

Challenges in the management of older patients with colon cancer.

Dotan E, Browner I, Hurria A, Denlinger C.

J Natl Compr Canc Netw. 2012 Feb;10(2):213-24; quiz 225. Review.

28.

A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.

Dotan E, Meropol NJ, Burtness B, Denlinger CS, Lee J, Mintzer D, Zhu F, Ruth K, Tuttle H, Sylvester J, Cohen SJ.

J Gastrointest Cancer. 2012 Dec;43(4):562-9.

29.

Challenges in the management of stage II colon cancer.

Dotan E, Cohen SJ.

Semin Oncol. 2011 Aug;38(4):511-20. doi: 10.1053/j.seminoncol.2011.05.005. Review.

30.

Gastric mucosa-associated lymphoid tissue lymphoma.

Morris GJ, Dotan E, Smith MR, Hagemeister FB Jr, Brereton HD.

Semin Oncol. 2010 Jun;37(3):183-7. doi: 10.1053/j.seminoncol.2010.05.013. No abstract available.

PMID:
20709202
31.

Optimizing chemotherapy regimens for patients with early-stage breast cancer.

Dotan E, Goldstein LJ.

Clin Breast Cancer. 2010;10 Suppl 1:E8-15. doi: 10.3816/CBC.2010.s.002. Review.

PMID:
20587409
32.
33.

Circulating tumor cells: evolving evidence and future challenges.

Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ.

Oncologist. 2009 Nov;14(11):1070-82. doi: 10.1634/theoncologist.2009-0094. Epub 2009 Nov 6. Review.

34.

The prevalence of pantoprozole associated thrombocytopenia in a community hospital.

Dotan E, Katz R, Bratcher J, Wasserman C, Liebman M, Panagopoulos G, Spaccavento C.

Expert Opin Pharmacother. 2007 Sep;8(13):2025-8.

PMID:
17714057

Supplemental Content

Loading ...
Support Center